Episode 22: Fixing First Fills with Trond Waerness from MedVantx
November 20, 201437:53

Episode 22: Fixing First Fills with Trond Waerness from MedVantx

Trond Waerness is the Vice President of Business Development at MedVantx, which is the leading provider within point-of-care medication adherence and direct-to-patient consumer engagement programs, through its MedStart™ Connect Cabinets, pharmacist staffed call center and two mail order pharmacies.

Trond has 18 plus years of marketing, operations, sales and sales management experience within the pharmaceutical industry, both on the manufacturer side and the vendor/services side. He has worked for two of the largest pharmaceutical manufacturers, and has also been involved in launching two pharmaceutical startup companies.

Having worked in, and been exposed to nearly every aspect of the commercial side of the pharmaceutical industry, Trond is able to draw on that experience when trying to overcome challenges within medication access, promotion and adherence. He has a strong passion for the pharmaceutical industry in general, how it can be improved, and how we can reduce the cost of healthcare in the US through disruptive innovation, efficiencies and new thinking.

LinkedIn: Trond Waerness
Email: trond.waerness@medvantx.com
MedVantx medvantx.com 

 

00:00 Trond talks about who he is and his career journey.
1:00 Trond talks adherence.
1:20 Symptomatic vs. Asymptomatic diseases.
2:15 “We estimate that less than 50% of patients adhere to their prescriptions and medication regimens.”
5:50 How MedVantx might improve adherence.
6:15 What Primary Adherence is.
7:00 What a Medstart Connect Cabinet is, where it is located, how it works and helps.
8:45 “There is a huge drop off of the number of prescriptions that are written and the number that are picked up at the pharmacy.”
11:00 Things that MedVantx is attempting to improve upon in healthcare.
12:30 The different types of health systems that MedVantx works with, and how.
18:30 “We have to be diplomatic in our approach.”
19:15 The big benefits of having Medstart Connect Cabinets in your health system.
19:50 There is a lot of responsibility in having these prescription drugs sitting in a closet.
20:30 The benefits of Medstart Connect Cabinets for the patients and ultimately health system quality standards.
21:40 Health Systems that use Medstart Connect Cabinets have seen improvement in their star ratings.
23:00 “Only about 8 or 9% of patients in this country use mail-order pharmacies.”
23:20 Because of this, there is little to no competition between MedVantx and regular, walk-in pharmacies.
24:00 The types of data that MedVantx collects.
25:20 Who MedVantx shares this data with and why.
27:45 Who pays for this program adherence.
30:00 “The healthcare industry has changed so much in the last five years, no one can be sure what the future holds, but one thing we do know is the work that we do in the healthcare space right now is very very good.”
31:10 Trond’s advice for businesses wanting to develop strategies for pushing their medication.
33:00 You can reach Trond on LinkedIn, via his email, and find out more about MedVantx online at medvantix.com.

medvantx,first fills,primary adherence,mail-order,
|
|

Episode Support Provided By

Special Thanks to Our 2026 Sustaining Monthly Donors

Marilyn Bartlett, Kimberly Carleson, Dylan Yahn, Benjamin Light, Matt McQuide, Ann Kempski, Spencer Allen, Scott Tromanhauser, 
Steven Elkins, Matthew Bunte, and Lori Smith.

Recent Episodes

EP533: Level Funding Is Self-funding: 5 Avoidable Contract Risks, With Frank Pennachio
Relentless Health ValueOctober 14, 2026
533
37:1334.07 MB

EP533: Level Funding Is Self-funding: 5 Avoidable Contract Risks, With Frank Pennachio

Hello, all you Relentless Tribe members. Thanks for hanging with me today to talk about a bunch of things. One of them being what exactly are level-funded plans, and what are the upsides, and then what are the risks? Because here's the thing. I was talking to an employer the other day, an employer w...

EP532: Why Avoidable ER Visits Aren't the Real Cost Problem: Revisiting Our 2016 Interview With HHS Nominee Chris Klomp
Relentless Health ValueOctober 07, 2026
532
37:2034.17 MB

EP532: Why Avoidable ER Visits Aren't the Real Cost Problem: Revisiting Our 2016 Interview With HHS Nominee Chris Klomp

Listen on Your Favorite App Today we are dipping into the archives for an essential replay from 2016, one decade ago, featuring Chris Klomp back when he served as CEO of a company called Collective Medical. With the nomination of Chris Klomp to serve as deputy secretary of the Department of Health a...

EP531: Slaying the Three-Headed Monster of Health Plan Networks, With Evan Anderson
Relentless Health ValueSeptember 30, 2026
531
38:0634.88 MB

EP531: Slaying the Three-Headed Monster of Health Plan Networks, With Evan Anderson

Listen on Your Favorite App Today, Evan Anderson and I are talking about carrier networks, how they started, how it's going. Because irrespective of whatever the plan was at the very beginning, any given network, especially talking about the big status quo networks, has evolved into what I'll call a...

EP530: A Wildly Underappreciated Point: Overpaying for Infusions Means Overpaying for Stop-Loss Coverage, With Jake Velie and Keith Hartman, RPh
Relentless Health ValueSeptember 23, 2026
530
37:4534.56 MB

EP530: A Wildly Underappreciated Point: Overpaying for Infusions Means Overpaying for Stop-Loss Coverage, With Jake Velie and Keith Hartman, RPh

Listen on Your Favorite App Hello, all you Relentless Tribe members. Thanks for hanging with me this week. When a self-insured plan sponsor sees an infusion claim hit their high-cost case report, and a lot of these infusions are really expensive, so many of them hit the high-cost claim report. For a...

EP529: How Stark Law, Stipends, and Noncompetes Drive Hospital Consolidation, With Eric Bricker, MD
Relentless Health ValueSeptember 16, 2026
529
39:2936.14 MB

EP529: How Stark Law, Stipends, and Noncompetes Drive Hospital Consolidation, With Eric Bricker, MD

Listen on Your Favorite App Hello, all you Relentless Tribe members. Hey, thanks for being here with me every week, some of you every single Thursday. Give yourself a little round of applause, maybe silently and in your own head, depending on where you are. But yeah, you matter. You being here matte...

EP528: The Current State of Primary Care—Inevitable or Fixable? Will It Be Private Equity to the Rescue? With Yashaswini Singh, PhD
Relentless Health ValueSeptember 09, 2026
528
38:4935.53 MB

EP528: The Current State of Primary Care—Inevitable or Fixable? Will It Be Private Equity to the Rescue? With Yashaswini Singh, PhD

Listen on Your Favorite App Hello, all you Relentless Tribe members. Here's the backstory for this episode. Remember episode 519 with Lisa Rosenbaum, MD, where we played a high-stakes kind of game show called "Is the Current State of Primary Care an Absolute Inevitability, or Is It a Needless, Subop...

EP526: Generic Compliance Ratios, Pass-Through Contracts, and Other Pharmacy Plumbing, With Mark Cuban and Cora Opsahl
Relentless Health ValueAugust 26, 2026
526
20:1119.06 MB

EP526: Generic Compliance Ratios, Pass-Through Contracts, and Other Pharmacy Plumbing, With Mark Cuban and Cora Opsahl

Listen on Your Favorite App Hello, all you Relentless Tribe members. If you have listened to this show for any length of time, you know one of our favorite truths around here, which is where there's mystery, there's margin. But today, we aren't just here to point out the mystery. We're here to look ...

Listen and Follow

Sponsored by Aventria Health Group
©2026 BD Bridges LLC. All Rights Reserved.